Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
With FDA rejection for eye drug, Aldeyra plans speedy new trial
Aldeyra Therapeutics had prepared for the worst and now it's here. The FDA has rejected the dry eye drug reproxalap.
Annalee Armstrong
Nov 28, 2023 4:30am
FDA rebuffs Entrada's attempt to get DMD clinical hold lifted
Nov 22, 2023 9:25am
Inovio drafts accelerated approval talking points for FDA visit
Nov 10, 2023 7:28am
Nurix's cancer drug on partial hold while manufacturing upgraded
Nov 2, 2023 8:40am
FDA advisers wave through first CRISPR-based therapy
Nov 1, 2023 11:07am
Deciphera's tumor-tackling oral med achieves 40% response rate
Oct 30, 2023 11:00am